BCR/ABL signal transduction

スポンサーリンク

概要

• 論文の詳細を見る

著者

• TAUCHI Tetsuzo

  First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

• Tsunoda Tatsuhiko

  Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res

• Tauchi T

  First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University

• TAUCHI Tetsuzo

  Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Walther Oncolog

• BROXMEYER Hal

  Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Department of M

• Tauchi Tetsuzo

  Department Of Hematology Division Tokyo Medical University

• Tauchi Tetsuzo

  Department Of Medicine (hematology/oncology) Indiana University School Of Medicine Walther Oncology

• Broxmeyer Hal

  Department Of Medicine (hematology/oncology) Indiana University School Of Medicine Department Of Mic

関連論文

• OE-294 A Functional Variation in a Gene Encoding One of Galectin-2 Binding Proteins Confers Risk of Myocardial Infarction in Asian Populations(OE50,Coronary Circulation/Chronic Coronary Disease (Basic/Clinical) (IHD),Oral Presentation (English),The 73rd A
• OE-009 Identification of a Locus on Chromosome 5p that Confers Risk of Coronary Artery Disease by Genome Wide Association Study(OE02,ACS/AMI (Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• FRS-004 Large Scale SNPs Association Study to Identify Genes Confer Risk of Myocardial Infarction(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Socie
• Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
• Spontaneous Regression of Pulmonary Infiltration of Adult T-Cell Leukemia/Lymphoma
• A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population
• A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction
• The characteristics of relapse in adult-onset minimal-change nephrotic syndrome
• PJ-152 A functional SNP in the Proteasome Subunit Alpha Type 6 Gene confers Risk of Myocardial Infarction in Japanese Population(Acute myocardial infarction, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-212 Identification of a Novel non-coding RNA, MIAT, that Confers Risk of Myocardial Infarction(Genetics/Genetically engineered models/Gene therapy-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4
• Arterial Stiffness in Patients with Non-Diabetic Chronic Kidney Disease (CKD)
• Low-Dose Losartan Therapy Reduces Proteinuria in Normotensive Patients with Immunoglobulin A Nephropathy
• Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy : a prospective study in a single center
• PJ-224 Primal role of intracellular zinc in PKC-dependent monocyte signalling and adhesive interaction(Atherosclerosis, basic(06)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
• Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy
• Can Eradication Therapy for Helicobacter pylori Really Inprove the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
• Thrombocytopenia Induced by Imatinib Mesylate(Glivec) in Patients with Chronic Myelogenous Leukemia : Is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
• Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10
• Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
• Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia
• Cloning, expression analysis, and chromosomal localization of a novel butyrophilin-like receptor
• Isolation and chromosomal mapping of a novel human gene showing homology to Na^+/PO4 cotransporter
• Expression profiles of two types of human knee-joint cartilage
• The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
• Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation
• BCR/ABL signal transduction
• Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor
• Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer
• Regulation of Hematopoiesis by Chemokine Family Members
• Reulation of egr-1 gene expression by retinoic acid in a human growth factor-dependent cell line
• Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
• SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population
• Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome
• Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function
• A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1
• Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function

もっと見る 閉じる

スポンサーリンク